S

Sangamo Therapeutics
D

SGMO

2.49000
USD
0.18
(7.56%)
Market Closed
Volume
247,636
EPS
-0
Div Yield
-
P/E
-3
Market Cap
519,530,706
OverviewSignalsIdeasNews
Related Instruments
    B
    BLUE
    -0.69000
    (-7.52%)
    8.49000 USD
    B
    BMRN
    0.695
    (1.07%)
    65.680 USD
    C
    CRSP
    0.360
    (0.89%)
    40.720 USD
    E
    EDIT
    -0.01000
    (-0.75%)
    1.32000 USD
    GILD
    GILD
    1.460
    (1.60%)
    92.570 USD
    N
    NTLA
    0.120
    (0.99%)
    12.190 USD
    More
News

Title: Sangamo Therapeutics

Sector: Healthcare
Industry: Biotechnology
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.